Inhibikase Therapeutics Inc (IKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,491 | 9,165 | 7,189 | 40,750 | 13,954 |
| Marketable Securities | 41,053 | 4,087 | 15,862 | N/A | N/A |
| Receivables | N/A | N/A | 40 | 110 | N/A |
| Other current assets | 81 | 220 | 1,118 | 107 | 774 |
| TOTAL | $98,451 | $14,211 | $24,371 | $42,470 | $14,783 |
| Non-Current Assets | |||||
| PPE Net | 47 | 73 | 237 | N/A | N/A |
| Other Non-Current Assets | 101 | 222 | 329 | 0 | 0 |
| TOTAL | $149 | $296 | $565 | $N/A | $N/A |
| Total Assets | $98,600 | $14,507 | $24,936 | $42,470 | $14,783 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 943 | 1,029 | 1,151 | 1,090 | 1,721 |
| Accrued Expenses | 2,680 | 2,260 | 2,398 | 2,716 | 633 |
| TOTAL | $3,734 | $3,439 | $3,695 | $4,055 | $4,722 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 2,326 |
| Other Non-Current Liabilities | 0 | 90 | 206 | 0 | 277 |
| TOTAL | $N/A | $90 | $206 | $N/A | $277 |
| Total Liabilities | $3,734 | $3,529 | $3,901 | $4,055 | $4,998 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,342 | 6,477 | 4,831 | 4,205 | N/A |
| Common Shares | 69 | 6 | 4 | 25 | 10 |
| Retained earnings | -94,421 | -66,901 | -47,872 | -29,818 | -15,032 |
| Other shareholders' equity | -37 | 1 | 105 | 0 | 0 |
| TOTAL | $94,866 | $10,978 | $21,035 | $38,416 | $9,784 |
| Total Liabilities And Equity | $98,600 | $14,507 | $24,936 | $42,470 | $14,783 |